-Trifluoromethyl Amines and Azoles: An Underexplored Functional Group in the Medicinal Chemist's Toolbox.

J Med Chem

Department of Medicinal Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 43183 Mölndal, Sweden.

Published: November 2020

AI Article Synopsis

Article Abstract

Introducing trifluoromethyl groups is a common strategy to improve the properties of biologically active compounds. However, -trifluoromethyl moieties on amines and azoles are very rarely used. To evaluate their suitability in drug design, we synthesized a series of -trifluoromethyl amines and azoles, determined their stability in aqueous media, and investigated their properties. We show that -trifluoromethyl amines are prone to hydrolysis, whereas -trifluoromethyl azoles have excellent aqueous stability. Compared to their -methyl analogues, -trifluoromethyl azoles have a higher lipophilicity and can show increased metabolic stability and Caco-2 permeability. Furthermore, -trifluoromethyl azoles can serve as bioisosteres of --propyl and --butyl azoles. Consequently, we suggest that -trifluoromethyl azoles are valuable substructures to be considered in medicinal chemistry.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.0c01457DOI Listing

Publication Analysis

Top Keywords

-trifluoromethyl azoles
16
-trifluoromethyl amines
12
amines azoles
12
-trifluoromethyl
8
azoles
8
azoles underexplored
4
underexplored functional
4
functional group
4
group medicinal
4
medicinal chemist's
4

Similar Publications

We aim to investigate whether chemical inhibition of NRF2 transcriptional activity (TA) influences distal colon contractions, particularly in an age-dependent manner in females, and whether it impacts oestrogen receptor signalling in female mice. This study was performed on 3 and 6-month-old female mice treated with ML385 (30 mg/kg) or a vehicle for 7 days (i.p.

View Article and Find Full Text PDF
Article Synopsis
  • Bladder cancer is more common in men and has high recurrence rates, particularly for non-muscle-invasive forms.
  • Transient receptor potential canonical channels (TRPCs), especially TRPC3, influence cancer cell behavior through calcium signaling, and the study investigates the effects of the TRPC3 inhibitor Pyr3 on bladder cancer cells.
  • Pyr3 treatment led to reduced cell viability, migration, and specific protein levels associated with cancer progression, indicating its potential as a therapeutic agent for bladder cancer by targeting PKC signaling.
View Article and Find Full Text PDF

FadD32, a fatty acyl-AMP ligase, plays an indispensable role in mycobacterial mycolic acid synthesis and is a validated target for tuberculosis (TB) drug development. The crystal structure of (Mtb)FadD32 has laid the foundation of structure-based drug discovery against this crucial enzyme. Here, we screened the "isoxazole" scaffold containing molecules against MtbFadD32 and identified a compound 2,4-dibromo-6-[3-(trifluoromethyl)-1,2-oxazol-5-yl]phenol (M1) with specific inhibitory activity against Mtb.

View Article and Find Full Text PDF

PPARβ/δ agonist GW0742 mitigates acute liver damage induced by acetaminophen overdose in mice.

Toxicol Appl Pharmacol

January 2025

Institute of Toxicology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China. Electronic address:

Liver damage caused by acetaminophen (APAP) overdose remains a worldwide medical problem. New therapeutic medicines for APAP poisoning are needed as the efficacy of the only antidote, N-acetyl-cysteine (NAC), significantly decreases if administered after 8 h of APAP intake and massive APAP overdose remains to induce hepatotoxicity despite the timely administration of NAC. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) possesses versatile roles including regulation of lipid homeostasis and anti-inflammation in the liver.

View Article and Find Full Text PDF

PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy.

Pharmacol Res

December 2024

Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona 08028, Spain; Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona 08028, Spain; Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM)-Instituto de Salud Carlos III, Madrid 28029,  Spain; Pediatric Research Institute-Hospital Sant Joan de Déu, Esplugues de Llobregat 08950, Spain. Electronic address:

Diabetic cardiomyopathy (DCM) is a specific type of myocardial disease that often develops in patients suffering from diabetes, which has become the foremost cause of death among them. It is an insidious multifactorial disease caused by complex and partially unknown mechanisms that include metabolic dysregulation, local inflammation, fibrosis, and cardiomyocyte apoptosis. Despite its severity and poor prognosis, it often goes undiagnosed, and there are currently no approved specific drugs to prevent or even treat it.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!